COVID-19: This Vacation Destination Offering Vaccinations To Visitors In Push To Lure Tourists COVID-19: This Vacation Destination Offering Vaccinations To Visitors In Push To Lure Tourists
Covid-19: This Vacation Destination Offering Vaccinations To Visitors In Push To Lure Tourists If you are dreaming of the white sands of the Maldives Islands and don't have a COVID-19 vaccine, no problem. The island is offering travelers vaccinations on arrival. In an interview on CNBC on Wednesday, April 14, the country's Tourism Minister Abdulla Mausoom told the network that the offer is part of its "3V" initiative aimed at drawing tourists to the hard-hit island resort located southwest of Sri Lanka and India. The strategy, Mausoom said, is to "visit, vaccinate, and vacation." Currently, visitors to the islands must provide a negative polymerase chain reaction test and proof of h…
COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines
Covid-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines The ratio of people who have suffered from blood clots after receiving the Moderna or Pfizer COVID-19 vaccine is approximately the same as those who receive the AstraZeneca vaccine, according to a new study. Oxford University researchers found that the number of people who receive blood clots after getting vaccinated is approximately the same for all three vaccines, with four in one million people experiencing cerebral venous thrombosis (CVT) after getting the Pfizer or Moderna vaccine, compared to five in one million people for the AstraZeneca vaccine. The new study comes in the wake of A…
COVID-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months COVID-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months
Covid-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months The Moderna COVID-19 vaccine loses a bit of its effectiveness after six months, though not as much as originally thought, according to the latest trial conducted by the pharmaceutical company. Moderna found in its latest trial that its COVID-19 vaccine maintains at least 90 percent of its efficacy in battling the virus after six months. Related story - COVID:19: COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients Researchers said the latest data evaluated 33 adults who participated in Phase 1 of Moderna’s vaccine study, which found the antibodies pers…
COVID-19: This University In Northeast Requiring Students Be Vaccinated Before Fall Semester COVID-19: This University In Northeast Requiring Students Be Vaccinated Before Fall Semester
Covid-19: This University In Northeast Requiring Students Be Vaccinated Before Fall Semester With the recent expansion of eligibility for the COVID-19 vaccine in Connecticut and around the country, at least one university in the state is requiring all students to receive a vaccine prior to returning to campus for the fall semester. Wesleyan University in Middletown announced this week that the decision was made to allow for all to return to "residential life and the close-knit, stimulating campus environment so meaningful to all of us." Exceptions to the rule would be those who have approved medical or religious reasons, the university added. For students who are currently on camp…
COVID-19: Have Your Completed Vaccine Card? Here's What To Do Now, Whether To Laminate It COVID-19: Have Your Completed Vaccine Card? Here's What To Do Now, Whether To Laminate It
Covid-19: Have Your Completed Vaccine Card? Here's What To Do Now, Whether To Laminate It For those who have their COVID-19 vaccine regimen completed and cherish the paper card that proves it, they might want to think twice before having it laminated. Number one is to make sure you have taken a photo of the card and that all of the information is correct and shows both shots. Health officials and those at the vaccine sites will tell you that having that photo as a backup before laminating will give you a backup in case you lose your card. Or if a state or federal passport is developed, you will have a way to transfer your information. It's easy to take a photo, email it to you…
COVID-19: Here's Percentage Of Americans Concerned About Getting Virus, New Poll Reveals COVID-19: Here's Percentage Of Americans Concerned About Getting Virus, New Poll Reveals
Covid-19: Here's Percentage Of Americans Concerned About Getting Virus, New Poll Reveals More and more Americans are expressing a willingness and openness to taking the COVID-19 vaccine as the country’s fear of contracting the virus has hit a new low, according to a newly released Gallup poll. In the latest poll, released this week, with “more needles” getting put in arms, just 35 percent of American adults are “very” or “somewhat” worried about contracting COVID-19, the lowest number since the organization began tracking the data in April last year. According to the poll, 22 percent of Americans are at least “moderately” worried about having access to hospital services and tre…
COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients
Covid-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients Those who have taken the Moderna COVID-19 vaccine are reporting more side effects than those who got a dose from Pfizer, according to a new study. Using data from more than three million vaccine recipients collected from the Centers for Disease Control and Prevention (CDC), it was determined that nearly 70 percent of those studied reported minor side effects such as fatigue or chills. Of those reporting side effects, the researchers found that more participants impacted had received the Moderna vaccine compared to the Pfizer vaccine. According to the study, 73 percent of those who got the…
COVID-19: Fourth Wave? Experts Disagree, But Say US At Tipping Point In Battle Vs. Virus COVID-19: Fourth Wave? Experts Disagree, But Say US At Tipping Point In Battle Vs. Virus
Covid-19: Fourth Wave? Experts Disagree, But Say US At Tipping Point In Battle Vs. Virus Who will win - the vaccine or the variants? That appears to be the question as to whether or not the United States could see a potential fourth wave of cases amid the COVID-19 pandemic. Two of the nation's top experts disagree but both are saying America is at a tipping point in the now more than one-year-long war against the virus.  Here's how it stands as of Monday, April 5.  More than one-third of American adults have received at least one dose of the vaccine. At the same time, there have been outbreaks of cases, especially in younger people, of the more contagious B.1.1.7 st…
COVID-19: FDA Approves Changes To Moderna Vaccine COVID-19: FDA Approves Changes To Moderna Vaccine
Covid-19: FDA Approves Changes To Moderna Vaccine The Food and Drug Administration has approved changes to the Moderna COVID-19 vaccine. On Thursday, April 1, the FDA announced that it has ruled that Moderna can put 50 percent more vaccine dosages in each vial, moving from 10 doses each to 15, which will allow for a more expeditious rollout of the vaccine. The FDA is also allowing 11 doses to be extracted out of the current 10 dose vials. Additionally, the FDA authorized the Moderna vaccine to be kept at room temperature conditions once removed from the refrigerator for administration for 24 hours, an increase from the previous 12 hours. …
COVID-19: All Adults 16+ To Be Eligible For Vaccine In CT COVID-19: All Adults 16+ To Be Eligible For Vaccine In CT
Covid-19: All Adults 16+ To Be Eligible For Vaccine In CT A new age group in Connecticut will be eligible to receive the COVID-19 vaccine as of Thursday morning. Gov. Ned Lamont said that Connecticut remains on track to expand COVID-19 vaccine eligibility to all adults over the age of 16 beginning on Thursday, April 1. Additionally, more than 100 additional pharmacies across Connecticut will be added to the state’s vaccination program. Originally, the final group - those between 16 and 44, were to become eligible for the vaccine as of Monday, April 5, but due to the state’s steady rollout of its vaccination program, they accelerated the plan. To…
AGs From 12 States Request Social Media Companies Block Anti-Vaxxers AGs From 12 States Request Social Media Companies Block Anti-Vaxxers
AGs From 12 States Request Social Media Companies Block Anti-Vaxxers Attorneys general from a dozen states are calling for social media companies to block anti-vaxxers.   The coalition of 12 attorneys general are calling on Facebook and Twitter to "take stronger measures to stop the spread of COVID-19 vaccine disinformation being spread by "anti-vaxxers" on their social media platforms" as stated in a public letter to the CEOs. The letter cites a report by the Center for Countering Digital Hate1, stating that “anti-vaxxer” accounts on Facebook, YouTube, Instagram, and Twitter reach more than 59 million followers. The letter specifically asks the CE…
COVID-19: CDC Director Warns Of 'Avoidable Rise In Cases,' Says US Is At Fork In Road COVID-19: CDC Director Warns Of 'Avoidable Rise In Cases,' Says US Is At Fork In Road
Covid-19: CDC Director Warns Of 'Avoidable Rise In Cases,' Says US Is At Fork In Road Centers for Disease Control and Prevention Director Rochelle Walensky is urging Americans to remain vigilant so the country doesn’t see an “avoidable rise in cases." Walensky warned on Monday, March 22 that another surge similar to what happened in the winter is “avoidable” as the federal government ramps up production and distribution of the COVID-19 vaccine. “I get it. We all want to return to our everyday activities and spend time with our friends, family, and loved ones,” she said. “But we must find the fortitude to hang in there just a bit longer. "We are at a critical point in this …